M&A Deal Summary |
|
|---|---|
| Date | 2023-06-13 |
| Target | RK Pharma |
| Sector | Life Science |
| Buyer(s) | PAG |
| Sellers(s) | Signet Healthcare Partners |
| Deal Type | Secondary Buyout |
SEARCH BY
| Category | Asset Manager |
|---|---|
| Founded | 2002 |
| PE ASSETS | 30.0B USD |
| Size | Mega |
| Type | Sector Agnostic |
PAG is a large independent alternative investment management group focused on private equity, real estate, and absolute returns. PAG’s private equity business, PAG Asia Capital or PAGAC, focuses on large-scale buyouts, control deals, and structured minority investments. PAG’s real estate strategy manages a series of real estate opportunity and core plus funds investing in properties in Japan, China and throughout Asia-Pacific. PAG’s absolute return business focuses on building long term relationships with its partners by offering a flexible range of financing solutions to meet short and long term funding needs. PAG was formed in 2002 and is headquartered in Hong Kong.
| DEAL STATS | # |
|---|---|
| Overall | 24 of 26 |
| Sector: Life Science M&A | 5 of 5 |
| Type: Secondary Buyout M&A Deals | 4 of 5 |
| State: New York M&A | 1 of 1 |
| Country: United States M&A | 1 of 1 |
| Year: 2023 M&A | 1 of 3 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2023-01-01 |
Vesco Foods
Osborne Park, Australia Vesco Foods is a producer of frozen ready meals with a market position in the private label/contract manufacturing segments primarily servicing the Retail channel. Vesco Foods was founded in 1974 and is based in Osborne Park, Western Australia. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2023-08-25 |
Australian Venue Co.
Melbourne, Australia Australian Venue Co. is a food and beverage-led hospitality group that owns and operates more than 210 pubs, bars, and event venues across Australia and New Zealand. Australian Venue Co. is based in Melbourne, Victoria. |
Buy | - |
| Category | Growth Capital Firm |
|---|---|
| Founded | 1998 |
| PE ASSETS | 600M USD |
| Size | Middle-Market |
| Type | Sector Focused |
Signet Healthcare Partners is a growth capital firm focused on the healthcare sector. Specific areas of interest include specialty pharmaceuticals, pharmaceutical services, medical devices, and diagnostics. Signet will consider opportunities throughout North America and Europe and looks to commit $10 to $50 million per transaction. Signet Healthcare Partners was established in 1998 and is headquartered in New York, New York.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 3 |
| Sector: Life Science M&A | 1 of 2 |
| Type: Secondary Buyout M&A Deals | 1 of 1 |
| State: New York M&A | 1 of 1 |
| Country: United States M&A | 1 of 3 |
| Year: 2023 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2023-03-07 |
Paragonix Technologies
Waltham, Massachusetts, United States Paragonix Technologies is a developer, manufacturer, and service provider in the organ transplant industry, establishing a novel approach to organ preservation. Paragonix Technologies provides Advanced Organ Preservation (“AOP”) devices that safeguard donor organs during the journey between donor and recipient patients. Paragonix Technologies is based in Waltham, Massachusetts. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2024-04-16 |
Curida
Elverum, Norway Curida offers contract development and manufacturing solutions to European pharmaceutical and biotech companies globally. Curida was founded in 2015 and is based in Elverum, Norway. |
Buy | - |
